Ajit Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.25 M
- Paid Up Capital ₹ 0.14 M
- Company Age 75 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.44 M
- Revenue Growth -11.26%
- Profit Growth -85.16%
- Ebitda -71.54%
- Net Worth -834.78%
- Total Assets -11.09%
About Ajit Laboratories
Ajit Laboratories Limited (ALL) was founded in India on 04 October 1949 and has a glorious history of 75 years and four months.Its registered office is in Sangli, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.25 M and a paid-up capital of Rs 0.14 M.
The company currently has active open charges totaling ₹0.44 M.
Uday Kulkarni, Anjali Kulkarni, Abhijit Kulkarni, and Three other members serve as directors at the Company.
Company Details
-
Location
Sangli, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24231PN1949PTC007807
-
Company No.
007807
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 Oct 1949
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Ajit Laboratories?
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aniruddha Kulkarni
|
Director | 30-Sep-2019 | Current |
|
Abhijit Kulkarni
|
Director | 21-May-2009 | Current |
|
Uday Kulkarni
|
Director | 23-Mar-1987 | Current |
|
Anjali Kulkarni
|
Director | 23-Mar-1987 | Current |
|
Avadhoot Kulkarni
|
Director | 30-Sep-2019 | Current |
|
Amruta Joshi
|
Director | 30-Sep-2019 | Current |
Financial Performance of Ajit Laboratories.
Ajit Laboratories Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 11.26% decrease. The company also saw a substantial fall in profitability, with a 85.16% decrease in profit. The company's net worth observed a substantial decline by a decrease of 834.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ajit Laboratories?
In 2023, Ajit Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.44 M
₹0
Charges Breakdown by Lending Institutions
- Union Bank Of India : 0.04 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Jul 2000 | Union Bank Of India | ₹0.08 M | Open |
| 28 Jun 1995 | Union Bank Of India | ₹0.15 M | Open |
| 20 Nov 1991 | Union Bank Of India | ₹0.11 M | Open |
| 22 Oct 1991 | Union Bank Of India | ₹0.10 M | Open |
How Many Employees Work at Ajit Laboratories?
Unlock and access historical data on people associated with Ajit Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ajit Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ajit Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.